TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

Completed · Phase 3 · Has a placebo group

Conditions studied: Lipodystrophy, HIV Infections

In brief

Assessing the Efficacy and Long-Term Safety of a 2 mg dose of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Subjects with Excess Abdominal Fat Accumulation

Key facts

Study ID

NCT00608023

Run by

Theratechnologies

People needed

263

Starts

2007-08-01

Expected to finish

2008-10-01

Last updated by the study team

2022-09-30

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have completed the 26 weeks treatment period of the TH9507-CTR-1011 study.
• Signed informed consent before any trial-related activities.

You may not qualify if…

• Fasting blood glucose >8.33 mmoL (150 mg/dL) at the end of the TH9507-CTR-1011 study.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Body Positive Inc. — Phoenix, Arizona, United States
• Somero, Michael — Indio, California, United States
• UCLA School of Medicine — Los Angeles, California, United States
• Office of Dr. Michael Somero — Palm Springs, California, United States
• University of California — San Francisco, California, United States
• Kaiser Permanente — San Francisco, California, United States
• UCSF/VA Medical Center — San Francisco, California, United States
• AIDS Research Alliance — West Hollywood, California, United States
• Denver Public Health Department — Denver, Colorado, United States
• Office of Dr. Gary Richmond — Fort Lauderdale, Florida, United States
• Hendry/Glades County Health Departments — LaBelle, Florida, United States
• Infectious Disease Research Institute Inc. — Tampa, Florida, United States
• AIDS Research Consortium Atlanta (ARCA) — Atlanta, Georgia, United States
• Northern Healthcare — Chicago, Illinois, United States
• Northstar Medical — Chicago, Illinois, United States
• Indiana University Department of Medicine — Indianapolis, Indiana, United States
• Tufts University School of Medicine — Boston, Massachusetts, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• The Research Institute — Springfield, Massachusetts, United States
• ID Associates — Hillsborough, New Jersey, United States
• AIDS Community Research Initiative of America — New York, New York, United States
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States
• University Hospitals of Cleveland — Cleveland, Ohio, United States
• Central Texas Clinical Research — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.